BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$3.67B |
| 2 |
S&P Global
SPGI
|
+$3.35B |
| 3 |
Tesla
TSLA
|
+$2.24B |
| 4 |
Microsoft
MSFT
|
+$1.42B |
| 5 |
JPMorgan Chase
JPM
|
+$1.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$4.51B |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$3.67B |
| 3 |
Meta Platforms (Facebook)
META
|
+$2.03B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.49B |
| 5 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$1.33B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.94% |
| 2 | Healthcare | 13.65% |
| 3 | Financials | 12.55% |
| 4 | Consumer Discretionary | 10.62% |
| 5 | Industrials | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
PUT
iShares MSCI EAFE ETF
EFA
$78.3B
| $14.7M | ﹤0.01% |
+200,000
| New | +$15M |
|
3327
Mizuho Financial
MFG
$125B
| $14.6M | ﹤0.01% |
5,697,964
+1,526,316
| +37% | +$4.18M |
|
3328
TPG
TPG
$7.24B
| $14.6M | ﹤0.01% |
+483,884
| New | +$15M |
|
|
DALS
3329
DELISTED
DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS
| $14.6M | ﹤0.01% |
1,501,060
| – | – |
|
|
TPBA
3330
DELISTED
TPB Acquisition Corporation I Class A Ordinary Share
TPBA
| $14.6M | ﹤0.01% |
1,499,800
| – | – |
|
3331
VistaGen Therapeutics
VTGN
$10.3M
| $14.5M | ﹤0.01% |
391,081
-5,392
| -1% | -$235K |
|
|
LUNA
3332
DELISTED
Luna Innovations Incorporated
LUNA
| $14.5M | ﹤0.01% |
1,884,605
-22,034
| -1% | -$158K |
|
3333
BlackRock Intermediate Muni Income Bond ETF
INMU
$541M
| $14.5M | ﹤0.01% |
600,000
-50,000
| -8% | -$1.24M |
|
3334
Citius Pharmaceuticals
CTXR
$16.1M
| $14.5M | ﹤0.01% |
323,287
-1,843
| -0.6% | -$72.8K |
|
3335
AerSale
ASLE
$303M
| $14.4M | ﹤0.01% |
917,919
+327,380
| +55% | +$5.03M |
|
|
LOGC
3336
DELISTED
ContextLogic
LOGC
| $14.4M | ﹤0.01% |
213,405
+18,791
| +10% | +$1.33M |
|
3337
Roblox
RBLX
$26.9B
| $14.4M | ﹤0.01% |
311,209
+226,029
| +265% | +$13.6M |
|
|
SRRA
3338
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $14.4M | ﹤0.01% |
448,430
+424,985
| +1,813% | +$12.2M |
|
3339
ACM Research
ACMR
$5.39B
| $14.3M | ﹤0.01% |
693,370
-12,452
| -2% | -$313K |
|
3340
Aldeyra Therapeutics
ALDX
$91.7M
| $14.3M | ﹤0.01% |
3,220,511
-8,300
| -0.3% | -$33.1K |
|
3341
Taysha Gene Therapies
TSHA
$1.65B
| $14.3M | ﹤0.01% |
2,193,703
-839,260
| -28% | -$6.27M |
|
3342
Citizens
CIA
$241M
| $14.3M | ﹤0.01% |
3,366,176
-95,982
| -3% | -$434K |
|
3343
Nkarta
NKTX
$150M
| $14.3M | ﹤0.01% |
1,253,706
-44,625
| -3% | -$477K |
|
3344
Vanguard Russell 1000 ETF
VONE
$8.38B
| $14.3M | ﹤0.01% |
68,822
+46,105
| +203% | +$9.42M |
|
3345
Blue Ridge Bankshares
BRBS
$318M
| $14.2M | ﹤0.01% |
937,804
-22,437
| -2% | -$375K |
|
|
MRUS
3346
DELISTED
Merus
MRUS
| $14.2M | ﹤0.01% |
536,800
-160,822
| -23% | -$4.31M |
|
|
ORGN
3347
DELISTED
Origin Materials
ORGN
| $14.2M | ﹤0.01% |
71,844
+120
| +0.2% | +$20.9K |
|
3348
Distribution Solutions Group
DSGR
$1.6B
| $14.2M | ﹤0.01% |
734,582
-3,250
| -0.4% | -$70.6K |
|
3349
Lightwave Logic
LWLG
$1.04B
| $14.2M | ﹤0.01% |
1,473,021
+38,426
| +3% | +$334K |
|
|
TEAD
3350
Teads Holding Co
TEAD
$75.7M
| $14.1M | ﹤0.01% |
1,317,366
+707,372
| +116% | +$8.89M |
|
Similar funds
BlackRock's Q1 2022 Portfolio in Review
As of Q1 2022, BlackRock held 6,014 positions worth $3.71T, down 5.5% from $3.93T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
BlackRock's Q1 2022 filing shows 170 new, 2,466 increased, 2,626 reduced and 167 closed positions. Its largest new stake was Constellation Energy: 21,495,337 shares worth $1.21B. The largest sale was Xilinx Inc, an estimated $4.51B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q1 2022 buy was Constellation Energy: 21,495,337 shares worth $1.21B.
- BlackRock added most to Advanced Micro Devices in Q1 2022, an estimated $3.67B increase.
- BlackRock's biggest Q1 2022 reduction was Meta Platforms (Facebook), cutting an estimated $2.03B.
- BlackRock fully exited Xilinx Inc in Q1 2022, selling an estimated $4.51B.
- BlackRock's ten largest holdings make up 21% of its $3.71T portfolio in Q1 2022.
- BlackRock opened 170 new positions and closed 167 in Q1 2022.
- BlackRock's portfolio value fell 5.5% quarter-over-quarter to $3.71T.
Based on BlackRock's 13F filing for Q1 2022, filed 12 May 2022.